WEST PALM BEACH, Fla., Jan. 29, 2015 /PRNewswire/ -- Glucose Health, Inc. (OTC: GLUC) ("Company") today announced the appointment of Chandrasekhar Mallangi, Ph.D., as an advisor to the Company, through the signing of an Agreement with CMS Consulting LLC, of which Dr. Mallangi is a principal.
Glucose Health, Inc. products serve the growing market of persons aware of the dangers of Type 2 diabetes and interested in proactive blood sugar health solutions. Dr. Mallangi will provide technical support including future development of additional dietary products derived from the Company's proprietary Glucose Health formula.
Dr. Mallangi spent more than 3 decades as a scientist and advisor to multinational companies in the development of nutritional products including health care and performance nutrition products, juices and tea-based beverages.
Additionally, Dr. Mallangi is the credited inventor or co-inventor for patents in the area of food nutrition, awarded by the United States Patent and Trademark Office www.uspto.org to Nestec, SA and Societe Des Produits Nestle S.A.; subsidiaries of Nestle, SA (OTC: NSRGY) of Vevey, Switzerland.
About Glucose Health, Inc.
Glucose Health, Inc. dietary products engage the large and growing market of consumers aware of the seriousness of Type 2 diabetes and proactively seeking natural blood sugar health solutions. The Centers for Disease Control and Prevention www.cdc.gov now estimates 2 in 5 adults - 40% of Americans - will develop Type 2 diabetes at some point in their lifetime. Glucose Health, Inc. dietary products are marketed to pharmacy retailers, through online marketplaces and via the Company's product website www.glucosehealth.com.
For further information about Glucose Health, Inc., please call 1-888-987-6315 (press 1).
SOURCE Glucose Health, Inc.